Abstract
During the European 2016/17 influenza season, A(H3N2) viruses have predominated and the majority clustered in genetic subclade 3C.2a1. Genetic analyses showed that circulating viruses have undergone considerable genetic diversification of the haemagglutinin gene from the current vaccine virus A/Hong Kong/4801/2014 (clade 3C.2a), but the antigenic data that is limited by the challenges with the antigenic characterisation of currently circulating A(H3N2) viruses, showed no clear evidence of antigenic change. The recommended A(H3N2) vaccine component for the northern hemisphere 2017/18 influenza season remained unchanged. However, early and mid-season vaccine effectiveness (VE) estimates were suggestive of reduced VE against A(H3N2) viruses.
Original language | English |
---|---|
Pages (from-to) | 4828-4835 |
Number of pages | 8 |
Journal | Vaccine |
Volume | 35 |
Issue number | 37 |
DOIs | |
Publication status | Published - 5 Sept 2017 |
Bibliographical note
Publisher Copyright:© 2017
Keywords
- A(H3N2)
- Amino acid substitution
- Emergence
- Europe
- Influenza virus
- Season
- Surveillance